4.7 Article Proceedings Paper

Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Ophthalmology

Clinical predictors of survival in metastatic uveal melanoma

Daniel Lorenzo et al.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2019)

Article Oncology

Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis

Douglas B. Johnson et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Review Oncology

New Insights into Molecular Oncogenesis and Therapy of Uveal Melanoma

Sara Silvia Violanti et al.

CANCERS (2019)

Review Oncology

Treatment of uveal melanoma: where are we now?

Jessica Yang et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)

Article Oncology

Identification of an Immunogenic Subset of Metastatic Uveal Melanoma

Luke D. Rothermel et al.

CLINICAL CANCER RESEARCH (2016)

Review Oncology

Uveal melanoma as a target for immune-therapy

Marc Oliva et al.

ANNALS OF TRANSLATIONAL MEDICINE (2016)

Article Oncology

Relative survival of patients with uveal melanoma managed in a single center

Josep Maria Caminal et al.

MELANOMA RESEARCH (2012)

Article Ophthalmology

Uveal Melanoma: Trends in Incidence, Treatment, and Survival

Arun D. Singh et al.

OPHTHALMOLOGY (2011)

Review Oncology

Targeted therapy for uveal melanoma

Pierre L. Triozzi et al.

CANCER TREATMENT REVIEWS (2008)